Trueblood Wealth Management »

Perspective Therapeutics shares owned by Trueblood Wealth Management

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Trueblood Wealth Management from 13F filings

Historical chart of Trueblood Wealth Management investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Trueblood Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Trueblood Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $237k 69k 3.43
2025-06-30 $238k 69k 3.44
2025-03-31 $47k 22k 2.13
2024-12-31 $71k 22k 3.19

More positions owned by Trueblood Wealth Management

JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Oracle Corporation (ORCL)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Ft Vest Ris (RDVI)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exchange-traded A Com Shs (FTA)
Arthur J. Gallagher & Co. (AJG)
Cincinnati Financial Corporation (CINF)
Caterpillar (CAT)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Republic Services (RSG)
First Tr Exchange Traded Dj Glbl Divid (FGD)

View all positions for Trueblood Wealth Management

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Morgan Stanley
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
State Street Corporation
Hills Bank And Trust Company
UBS Group
Walleye Trading Advisors
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics